PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35533600-0 2022 Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/ androgen receptor signaling pathway. Lycopene 0-8 androgen receptor Homo sapiens 112-129 35533600-6 2022 In addition, the expression of p-AKT, p-EZH2 and androgen receptor (AR) were significantly down-regulated in 22RV1 and C4-2B cells and the proliferation and invasion of CRPC cells were inhibited after treatment with lycopene, while SC79 (an AKT agonist) markedly rescue this effect. Lycopene 216-224 androgen receptor Homo sapiens 49-66 35533600-6 2022 In addition, the expression of p-AKT, p-EZH2 and androgen receptor (AR) were significantly down-regulated in 22RV1 and C4-2B cells and the proliferation and invasion of CRPC cells were inhibited after treatment with lycopene, while SC79 (an AKT agonist) markedly rescue this effect. Lycopene 216-224 androgen receptor Homo sapiens 68-70 35533600-8 2022 These results suggest that the enhanced antitumor effects of enzalutamide by lycopene may be related to the reduction of AR protein levels through lycopene-mediated inhibition of AKT/EZH2 pathway, which may provide a new approach to improve the efficacy of enzalutamide in CRPC. Lycopene 77-85 androgen receptor Homo sapiens 121-123 35533600-8 2022 These results suggest that the enhanced antitumor effects of enzalutamide by lycopene may be related to the reduction of AR protein levels through lycopene-mediated inhibition of AKT/EZH2 pathway, which may provide a new approach to improve the efficacy of enzalutamide in CRPC. Lycopene 147-155 androgen receptor Homo sapiens 121-123 20819671-16 2010 CONCLUSIONS: Lycopene as an antioxidant dietary factor could significantly inhibit DNA synthesis in a dose-dependent pattern; the result revealed lycopene might inhibit androgen receptor gene element activity and expression. Lycopene 13-21 androgen receptor Homo sapiens 169-186 20819671-0 2010 Effect of lycopene on androgen receptor and prostate-specific antigen velocity. Lycopene 10-18 androgen receptor Homo sapiens 22-39 20819671-2 2010 This study was carried out to evaluate the impact of the dietary factor lycopene on DNA synthesis, activity and expression of the androgen receptor gene element in prostate LnCaP cells and to report our pilot phase II study investigating its effect on prostate-specific antigen velocity over one year. Lycopene 72-80 androgen receptor Homo sapiens 130-147 20819671-5 2010 A transient transfection of a plasmid DNA recombinant containing an androgen receptor element-luciferase (ARE-Luc) report gene into LnCaP cells was developed and the impact of different concentrations of lycopene on the androgen receptor element was reflected by quantitative analysis of the luciferase enzyme function. Lycopene 204-212 androgen receptor Homo sapiens 220-237 20819671-10 2010 We showed for the first time that lycopene inhibited the activity of the androgen receptor gene element in a dose-related manner. Lycopene 34-42 androgen receptor Homo sapiens 73-90 20819671-16 2010 CONCLUSIONS: Lycopene as an antioxidant dietary factor could significantly inhibit DNA synthesis in a dose-dependent pattern; the result revealed lycopene might inhibit androgen receptor gene element activity and expression. Lycopene 146-154 androgen receptor Homo sapiens 169-186 17121935-6 2006 The binding of lycopene to the ligand-binding domain of the human androgen receptor was carried out, but lycopene was not found to be a ligand for this receptor. Lycopene 15-23 androgen receptor Homo sapiens 66-83 18283040-11 2008 In this study, lycopene, in dietary concentrations, reversed DHT effects of 6S cells on NPE cell death, decreased 6S cell IGF-I production by reducing AR and beta-catenin nuclear localization and inhibited IGF-I-stimulated NPE and PREC growth, perhaps by attenuating IGF-I"s effects on serine phosphorylation of Akt and GSK3beta and tyrosine phosphorylation of GSK3. Lycopene 15-23 androgen receptor Homo sapiens 151-153